Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Dicks Sporting Goods Inc (DKS) Price & Performance

Charles River Laboratories Intl. IncTrade
Dicks Sporting Goods IncTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Dicks Sporting Goods Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $302.26 (market cap $14.23B), while Dicks Sporting Goods Inc trades at $135.31 (market cap $13.26B). The key difference: Charles River Laboratories Intl. Inc and Dicks Sporting Goods Inc are close in size by market cap, and Dicks Sporting Goods Inc pays a 3.71% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Dicks Sporting Goods Inc for 19 Days on average.

CRLDKS
Market Cap
$14.23B$13.26B
Volume
1,176,8852,292,035
Sector
HealthConsumer Cyclical
52-Week High
$310.77$239.17
52-Week Low
$149.93$121.15
Typical Hold Time
33 Days19 Days
Enterprise Value
$17.06B$20.31B
Dividend Yield
—3.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.

The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.

Dicks Sporting Goods Inc

DICK'S Sporting Goods (DKS) trades at $134.91, up 2.84% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains solid fundamentals with a P/E of 14.86 and ROE of 18.47%, though recent earnings showed a Q2 2026 miss. Analyst consensus remains strongly positive with 56.9% buy ratings and a $153.30 price target, representing 13.6% upside potential from current levels.

While facing securities litigation headwinds, DKS demonstrates operational strength with $1.31B operating cash flow and consistent dividend payments. The stock offers value with attractive valuation metrics, but investors should monitor the ongoing class action lawsuits and potential impact on near-term sentiment despite the fundamentally sound business model.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRL
0% Buy100% Sell
Avg holding period · 33 Days
DKS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL →

About Dicks Sporting Goods Inc

Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.

Read more on DKS →